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Introduction
Vaccinations are the greatest achievement in public health, helping to shift
mortality rates in developed nations from communicable disease to chronic disease.
However, in the United States (U.S.), approximately 42,000 adults and 300 children still
die annually from vaccine-preventable diseases.1
Cases of pertussis in the U.S. decreased dramatically after the vaccine was
developed in the 1940s; however, since the 1980s, the number of reported cases has
been gradually increasing. In 2010, more cases were reported than any year since
1959.2 In 2012, the Centers for Disease Control and Prevention (CDC) recorded a
record 48,277 cases of pertussis in America.3 Approximately half of infants who contract
pertussis will be hospitalized, and 1% of those will die, often from a secondary bacterial
pneumonia.3 Economic burden from childhood pertussis includes lost work days by
parents, visits to healthcare providers, antibiotic medications, and often costs of
hospitalization. A retrospective study in Monroe County, New York estimated that on
average, $3561 of indirect and direct costs resulted per individual case of pertussis in
1997.4 This cost estimate does not take into consideration the perverse inflation in
American healthcare costs over the past 15 years, nor the associated public health
costs of outbreak surveillance and containment.
It is well known that vaccination has majorly decreased the incidence of pertussis
and pertussis related deaths among Americans over the past few decades; however, in
the past 5 years, diagnoses of pertussis have begun to increase. When pertussis
incidence is stratified by age, it has been found that the rise is most prominent in
adolescents aged 11-18 and adults greater than 19 years of age.5 Adolescents and
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adults often carry a subclinical form of the disease, which means they may be less likely
to seek medical treatment, and the number of reported cases might be falsely low.6
These infected adults can then transmit pertussis to infants, where the bacteria cause a
much more virulent and sometimes deadly infection.
The cause for increased incidence of pertussis is thought to be multifactorial, but
has not been extensively studied. One possible reason is that the efficacy of TDaP and
DTaP vaccines is not as high as other vaccinations. Acellular pertussis vaccines (TDaP)
replaced whole cell vaccines (DTwP) for adults and teenagers in 2005.5 Therefore,
there are very limited data on TDaP vaccination long-term efficacy and efficacy at
reducing transmission to infants. The childhood acellular vaccine (DTaP) has an
efficacy of 88.7-97% immediately after completion of the immunization sequence.7,8
However, evidence is growing that the DTaP vaccine produces a waning immunity to
pertussis.9
Another possible explanation is that due to increased attention to pertussis rates,
physicians have become more diligent in testing sick children for the disease. Reasons
a practitioner may not conduct a pertussis diagnostic test are delay in obtaining test
results, inconvenience of collecting samples, lack of testing supplies, lack of familiarity
with testing protocols, and cost.10 Growing pressure from the media and concerned
parents may be motivation for providers to overcome barriers to testing.
The focus of this study is to evaluate the possible role parental acceptance of
vaccination plays in pertussis incidence. If fewer children are vaccinated, it is logical that
pertussis incidence would increase. Several studies have attempted to identify factors
that influence parents’ decisions to vaccinate adolescents with TDaP. The factor
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commonly associated with an increased likelihood to vaccinate was provider
recommendation, while low perceived risk of getting pertussis was the most common
barrier to vaccination.11,12 Another barrier was that adolescents are less likely than
young children and infants to see a healthcare provider on a regular basis.13
Requiring vaccination in school-aged children has had tremendous impact on
controlling preventable disease outbreaks. In 1977, a CDC study concluded that states
requiring vaccination before school entry experienced measles incidence rates 40-50%
lower than states that did not.14 In Kentucky, vaccination is required to attend public and
private school. Despite the overwhelming evidence that vaccines are safe and effective,
every state has vaccination exemption laws. All 50 states allow vaccination exemption
for medical reasons. Children with compromised immune systems and those with
previous allergic reactions or adverse effects associated with vaccination would fall into
this category. In these children, vaccination may be unsafe. Several states also allow
religious exemptions, and others allow religious and philosophical exemptions. The
process for obtaining exemptions also varies by state.
The recent measles outbreak at Disneyland15 has called into question the
stringency of vaccination exemption laws. Although it seems logical to assume a
correlation, published literature linking vaccination exemption obtainment with disease
incidence is sparse. One study of New York state schoolchildren found that counties
with higher rates of exemption also experienced increased incidence of pertussis
among both vaccinated and unvaccinated children when compared to counties with low
exemption rates.16 It is hypothesized that the same correlation would be observed in
Kentucky, because like New York, the law allows both medical and religious
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exemptions. The process for obtaining a religious exemption is also similar between the
two states, requiring the parents to sign a document saying they understand the risks
but object to vaccination for religious reasons.17,18 In Kentucky, this form must be signed
by a healthcare provider, pharmacist, local health department or other licensed
healthcare facility.18 In New York, the form must also be notarized.17
The primary objective of this study was to determine if a county-level association
existed between vaccination exemptions among school-aged children and pertussis
incidence during the years 2004-2012. Secondarily, a regional analysis was conducted
to determine if Appalachian counties reported higher rates of exemption than nonAppalachian counties. The Appalachian area has many health disparities in maternal
and child health, including lack of access to care, low socioeconomic status, and low
educational attainment.
Research on the health impact of legal vaccination exemptions provides valuable
information for use when lobbying for vaccination initiatives in the legislature. If
statistically significant associations are found, further research regarding the public
health outcomes of parents’ decisions to vaccinate or seek exemption is highly
warranted. This glimpse into vaccination exemptions in Kentucky could be a starting
point for legislative reform in Kentucky.
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Methods
Institutional Review Board Exemption
Because the data do not contain protected health information, the study received
IRB exemption from both the University of Kentucky and Kentucky Cabinet for Health
and Family Services (CHFS) Institutional Review Boards.
Data Source
This study investigated the correlation between vaccination exemption in
kindergarten and sixth grade and pertussis incidence in all 120 Kentucky counties
between 2004 and 2012. Kentucky schools are required to submit a Commonwealth of
Kentucky School/Facility Annual Immunization Survey to their county health
department.19 The county health department then sends a report to the epidemiologists
at the Immunization Program at Kentucky CHFS. This study used the epidemiological
reports for all kindergarten and sixth grade immunizations along with statewide
Communicable Disease Case Reports submitted to CHFS from 2004-2012.
Study Design
This study retrospectively analyzed data from 120 Kentucky counties from 20042012. If <50% of schools within a county submitted Immunization Surveys in a given
year, the county was excluded from analysis. Study design closely mirrored a similar
study published in 2013 with data from New York State.16 Annual county exemption
rates were calculated as the percent of exemption certificates out of the total number of
kindergarten and sixth grade students per county, as reported in the Annual
Immunization Survey. This served as the independent variable. Overall annual
exemption rates for the state were also calculated in this manner. The correlation
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between exemptions and pertussis for the years 2004 through 2012 was tested using
non-parametric Spearman analysis because data were not normally distributed.
Changes in vaccination exemption rates and pertussis incidence over time from 2004 to
2012 were analyzed using Friedman tests, the non-parametric analog to repeated
measures analysis of variance (ANOVA).
The total number of pertussis cases reported in each county over all age groups
per year was used as the dependent variable because age-specific data were not
available. US Census Bureau 2010 total county populations were used to calculate the
incidence rate per 100,000.
In addition, counties were categorized via a median split into two groups
representing those with higher versus lower exemption rates: Above Median Group
(AMG) and Below Median Group (BMG). A non-parametric Mann-Whitney U test was
performed to test for a statistically significant difference in pertussis incidence between
the two groups.
Finally differences in pertussis incidence and exemptions between Appalachian
and non-Appalachian counties were also analyzed using non-parametric Mann-Whitney
U tests.
All analyses were conducted using SPSS (Version 22) software and all statistical
tests were two-tailed with alpha set at 0.05.
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Results
Descriptive Statistics
Of 1080 total reported cases (i.e. county in a given year), 937 were included for
analysis and 143 were excluded. The mean exemption rate was 0.5058 + 0.656
exemptions per 100 students. The median exemption rate was 0.3656 per 100 students.
The distribution of exemptions was skewed to the right and therefore non-parametric
tests were used to test for significant associations. Descriptive statistics are
summarized in Tables 1 and 2.
Correlation Analysis
A non-parametric Spearman test showed a statistically significant correlation
between overall vaccination exemptions and pertussis incidence (rho=0.176, p<0.001).
Time Analysis
Non-parametric Friedman tests were used to analyze difference over time in the
rates of vaccination exemption and pertussis in the 120 counties. There was a
statistically significant difference in vaccination exemption rates over the nine year
period, Χ2(8) = 119.576, p<0.001. There was also a statistically significant difference in
pertussis incidence over the nine-year period, Χ2(8) = 192.867, p<0.001. Both
vaccination exemption rates and pertussis incidence rates tended to increase over time.
The attached maps provide a visual representation of change in vaccination exemptions
in Kentucky counties in 2004 as compared to 2012 (Figures 1 and 2).
Median Split Analysis
The Below-Median Group (BMG) was defined as all cases with an exemption
rate <0.3656 per 100 students (n=468). The Above-Median Group (AMG) was defined
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as all cases with an exemption rate >0.3656 per 100 students (n=469). The BMG mean
pertussis incidence was 0.0044 + 0.019 per 100 people, compared to the AMG mean of
0.0066 + 0.014 per 100 people. Median pertussis incidence in groups BMG and AMG
were 0.00015 and 0.000 per 100 people; the distributions in the two groups differed
significantly (Mann-Whitney U=93595). Figure 3 illustrates the distribution of exemption
rate frequencies in both groups, in which the AMG distribution is shifted slightly to the
right compared to the BMG distribution.
Appalachian Analysis
The average pertussis incidence in Appalachian cases was 0.00531 + 0.021 per
100 people (n=416). The average pertussis incidence in non-Appalachian cases was
0.00568 + 0.013 per 100 people (n=521). Median incidence in both groups was 0.000;
however, the distributions in the two groups differed significantly (Mann-Whitney U =
96867, P=0.001). The attached histogram illustrates the distribution of pertussis rates in
the two groups (Figure 4), in which the proportion of non-zero incidence was higher in
non-Appalachian counties.
The average vaccination exemption rate in Appalachian counties was 0.4464 +
0.622 per 100 students. The average vaccination exemption rate in non-Appalachian
counties was 0.5533 + 0.677. Median exemption rates in Appalachian and nonAppalachian groups were 0.2834 and 0.4189 respectively. The distributions in the two
groups differed significantly (Mann-Whitney U= 92481, P<0.05). The attached histogram
illustrates the distribution of vaccination exemptions in the two groups (Figure 5), in
which the proportion of cases with non-zero exemption rates was higher in nonAppalachian counties.

	
  

10	
  

Discussion
Vaccinations are a controversial political and social topic. This study found that in
counties with higher rates of vaccination exemptions in school-aged children,
significantly higher pertussis incidence rates were observed. This finding mirrors the
results found in New York in 2000-2011.15 Research such as this is important as public
health advocates argue for more stringent childhood vaccination laws.
Additional analyses revealed that non-Appalachian counties reported higher
rates of vaccination exemption and also slightly higher rates of pertussis incidence than
non-Appalachian counties. This result supports the theory that more exemptions are
filed in high-income areas. This is a refreshing contrast to most published literature on
health in Appalachian areas and shows that although health disparities exist in the area,
pertussis incidence is not disproportionately higher in Appalachian counties.
Strengths of this study include a large sample size spanning several years of
collection. Also, exemption data were a census of schools for the given time period, not
a random sample. However, study limitations should be considered. Due to
inconsistencies in county-level reporting of data and state-level maintenance of records,
one case was defined as one county during one year of data collection. Therefore, the
same county population was used to calculate 9 different pertussis incidence rates,
even though countywide immunity would change from year to year as vaccination
trends changed. Data were structured in this way in order to maximize the sample size
and streamline statistical analyses. Future research using more complex longitudinal
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analyses with an accumulation of exemptions over time may yield more accurate
statistical results.
For future research, the data set compiled from the Commonwealth of Kentucky
School/Facility Annual Immunization Survey could yield a wealth of information about
Kentucky vaccinations. For example, the same study could be repeated using rate of
reported Tdap/Dtap vaccination as the independent variable instead of filed vaccine
exemption. This would factor in students who were not vaccinated or who did not
receive the entire vaccine series, but whose parents did not take the steps to file for
exemption. In theory, these students would be required to complete the vaccine series
in order to attend school. However, that is often not the case. This topic would
especially be interesting to study in Appalachian counties because it may better address
barriers to vaccination.
This research serves as a valuable stepping-stone for behavioral research
regarding parental decisions to abstain from vaccination. Such research is pivotal when
developing health initiatives and programs promoting vaccination of Kentucky children.
The current findings also provide ammunition for reform of vaccination exemption laws
in Kentucky. Changing the law to only allow for medical exemptions and/or to increase
the complexity of applying for a religious exemption could potentially increase
vaccination rates in Kentucky schoolchildren.
Many factors may influence a parent’s decision to vaccinate his or her child.
Although the current study did not examine parental decisions, results suggest that
higher rates of exemption sought by parents have an epidemiological impact on the
health of our state. It is in the best interest of our Commonwealth that public health
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officials and healthcare providers continue to stress the importance of vaccinations in
order to keep preventable communicable diseases, such as pertussis, at bay.
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Table 1: Descriptive Statistics of Vaccination Exemptions and Pertussis Incidence in
Kentucky Counties, 2004-2012
Overall
Above- Median
Below- Median
a
Group
Groupb
Total Cases
937
469
468
Mean Exemption
Rate
(per 100 students)

0.508 + 0.656

0.8907 + 0.738

0.1202 + 0.133

Median Exemption
Rate
(per 100 students)

0.3656

0.6977

0.0502

Range of Exemption 0.0 000 – 5.672
Rates
(per 100 students)

0.3656 – 5.672

0.0000 – 0.3636

Mean Pertussis
Rate
(per 100 people)

0.0055 + 0.0174

0.0066 + 0.0147

0.0044 + 0.0197

Median Pertussis
Rate
(per 100 people)

0.00

0.00

0.00

Range of Pertussis
Rates
(per 100 people)

0.0 – 0.3680

0.0 – 0.1587

0.0 – 0.3680

a

Above-Median Group refers to cases with vaccination exemption rates greater than or
equal to the overall median of 0.3656 per 100 students.
b
Below-Median Group refers to cases with vaccination exemption rates less than the
overall median of 0.3656 per 100 students.
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Table 2: Descriptive Statistics of Vaccination Exemptions and Pertussis Incidence in
Appalachian versus Non-Appalachian Counties in Kentucky, 2004-2012
Overall
Appalachian
Non-Appalachian
Total Cases
937
416
521
Mean Exemption
Rate
(per 100 students)

0.508 + 0.656

0.4464 + 0.622

0.5532 + 0.678

Median Exemption
Rate
(per 100 students)

0.3656

0.2834

0.4190

Range of Exemption 1.0 000 – 5.672
Rates
(per 100 students)

0.0 000 – 5.10

00000 – 5.67

Mean Pertussis
Rate
(per 100 people)

0.0055 + 0.0174

0.0053 + 0.0214

0.0057 + 0.0134

Median Pertussis
Rate
(per 100 people)

0.00

0.00

0.00

Range of Pertussis
Rates
(per 100 people)

0.0 – 0.3680

0.0 – 0.3680

0.0 – 0.1587

Figure 1: 2004 County-Level Vaccination Exemption Rates in Kentucky
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Figure 3:

Note: Below the Median refers to the Below-Median Group (BMG), including cases with
vaccination exemption rates less than the overall median of 0.3656 per 100 students.
Above the median refers to the Above-Median Group (AMG), including cases with
vaccination exemption rates greater than or equal to the overall median of 0.3656 per
100 people.
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